Mark Miller
Chief Investor Relations Officer
Replay available
Encompass Health Corporation (NYSE: EHC) Q1 2025 earnings conference call, held 2025-04-25. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
President and Chief Executive Officer
Executive Vice President and Chief Financial Officer
Analyst, Deutsche Bank Securities
Analyst, Lear Inc. Partners
Analyst, KeyBank
Analyst, Mizuho Securities
Analyst, Bank of America Securities
Analyst, Jefferies
Analyst, UBS
Analyst, William Blair & Company
Analyst, Barclays
Analyst, Raymond James
Good morning, everyone, and welcome to Encompass Health's first quarter 2025 earnings conference call. At this time, I'd like to inform all participants that their lines will be in a listen-only mode. After the speaker's remarks, there will be a question and answer period. If you would like to ask a question during this time, please press the star and 1 on your telephone keypad. You will be limited to one question and one follow-up question. Today's conference call is being recorded. If you have any objections to potentially being recorded, you may disconnect at this time. I'll now turn the call over to Mark Miller, Encompass Health's Chief Investor Relations Officer. Thank you, Operator, and good morning, everyone. Thank you for joining Encompass Health's first quarter 2025 earnings call. Before we begin, if you do not already have a copy, the first quarter earnings release supplemental information and related form 8K filed with the SEC are available on our website at encompasshealth.com. On page two of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control. Certain risks and uncertainties, like those relating to regulatory developments as well as volume, bad debt and cost trends that could cause actual results to differ materially from our projections, estimates, and expectations, are discussed in the company's SEC filings, including the earnings release and related Form 8K. the Form 10-K for the year ended December 31, 2024, and the Form 10-Q for the quarter ended March 31, 2025, when f...